CHAPTERS
- 0:00 – 1:17
Reconnecting at the comedy club and why MAPS matters
Joe welcomes Rick back, riffing on seeing Dave Chappelle at the club and Chappelle’s interest in psychedelic therapy. Joe frames MAPS’ work as culturally and socially significant, setting up Rick’s long arc from 1970s prohibition to today’s mainstream momentum.
- •Joe and Rick catch up after meeting at the comedy club
- •Dave Chappelle’s support and the idea of finding common ground
- •Joe praises MAPS as a major societal/cultural project
- •Rick reflects on dedicating his life to psychedelics since 1972
- 1:17 – 4:30
Draft resistance, civil disobedience, and the road into psychedelics
Rick explains his Vietnam-era draft resistance, why he chose nonviolent civil disobedience, and how he expected to go to jail. The experience shaped his identity and pushed him toward a nontraditional path—eventually aligning his life’s work with psychedelic therapy.
- •Rick’s reasoning for refusing to register for the draft
- •MLK’s framing of civil disobedience as respect for law
- •How psychedelics became a “career path” when conventional paths felt closed
- •Carter’s pardon and shifting from ‘criminal’ identity
- 4:30 – 7:10
Vietnam, whistleblowers, and patriotism as moral courage
The conversation expands from Vietnam’s legacy to false-flag fears and Daniel Ellsberg’s role with the Pentagon Papers. Rick and Joe connect patriotism to speaking up, taking consequences, and resisting unjust policies.
- •Vietnam as imperial overreach and the Gulf of Tonkin narrative
- •Daniel Ellsberg’s reflections on acting earlier
- •Civil disobedience as patriotism vs. blind compliance
- •Moral refusal when participation feels ethically wrong
- 7:10 – 10:35
Veterans, conservatives, and ‘be the bridge’ coalition-building
Rick describes how veteran PTSD work created unlikely alliances across the political spectrum. He cites SEAL and governor-level support, plus surprising outreach to figures like Ted Nugent, emphasizing MAPS’ strategy of bridge-building.
- •Veterans’ experiences shifting public perception of psychedelics
- •Ibogaine stories from special operators and high-profile advocates
- •Rick Perry and Marcus Luttrell’s influence on political support
- •Ted Nugent conversation as a case study in bridge-building
- 10:35 – 14:12
Ethical funding, polarization, and a Supreme Court dinner lesson
Rick recounts backlash after accepting a restricted donation from Rebekah Mercer and how Justice Stephen Breyer validated the democratic value of finding common ground. Joe ties it to resisting tribalism and ideological hardening.
- •Controversy around donor politics and restricted veteran funding
- •Breyer’s argument: democracy requires common-ground building
- •Hyper-partisanship vs. pragmatic collaboration
- •Chappelle as a cultural voice for bridge-building
- 14:12 – 23:36
Rogan’s DMT/5-MeO experiences and why psychedelics break rigid patterns
Joe shares profound DMT and 5-MeO-DMT experiences, emphasizing how they dissolve “armor” and challenge identity narratives. Rick adds a framework: default mode network weakening, deeper connection, and the importance of integration—especially across different durations (MDMA vs. ibogaine).
- •Joe’s description of DMT: ‘impossible realm’ and ego-layer stripping
- •5-MeO: fear at the doorway, minimal visuals, ‘source code’ feeling
- •Rick on default mode network, information flooding, and unity experiences
- •Integration as essential; duration differences across substances
- 23:36 – 47:08
Ibogaine: origins, addiction recovery, neuroplasticity, and US policy barriers
Rick traces ibogaine’s research lineage, including Aubrey Marcus’s father’s role in kickstarting studies, and argues it’s a prime example of failed drug policy. They discuss neuroplasticity, treatment potential for opioid withdrawal, safety considerations, and strategies to bring ibogaine into legitimate US medical channels.
- •Ibogaine’s effectiveness for opioid withdrawal and psychological insight
- •Neuroplasticity: longer psychedelic states can extend the ‘rewiring’ window
- •US illegality as a drug-war artifact despite low abuse potential
- •Safety issues (cardiac risk) and the case for supervised clinical access
- •Two-pronged plan: FDA pathway + rescheduling/decriminalization policy work
- 47:08 – 54:16
Drug-war framing, language, and propaganda (plus the Burning Man ‘pee’ detour)
After a comic interlude about bladder control post-surgery and Burning Man, the discussion returns to how the drug war will be viewed like Vietnam—an historic mistake. Joe and Rick critique loaded language (“drugs,” “hallucinogen”) and argue policy should focus on relationships, purity, and help—not punishment.
- •Rick’s prostate surgery/Burning Man story and Joe’s ‘diaper podcast’ joke
- •Drug war as a future moral failure akin to Vietnam’s reputation
- •Why terms like ‘drugs’ and ‘hallucinogen’ bias public perception
- •Carl Hart’s idea: the more dangerous the drug, the more important legal regulation becomes
- •Punishment-driven policy vs. treatment, support, and harm reduction
- 54:16 – 1:29:12
MDMA ‘holes in the brain’ myth, media incentives, and a notorious lab error
Rick details how sensational media (MTV/Oprah) amplified the false ‘brain holes’ narrative and how nuance was lost until long-form formats. He then recounts a major scientific scandal: a primate study claiming MDMA harmed dopamine was later retracted when it turned out methamphetamine was mistakenly administered—yet the fear-messaging persisted.
- •How SPECT images were manipulated into ‘holes’ propaganda
- •Oprah’s cancelled ‘benefits’ segment after a clean follow-up scan
- •Why long-form podcasts allow nuanced risk/benefit discussions
- •Retracted primate paper: methamphetamine substituted for MDMA
- •Grant incentives and confirmation bias shaping anti-drug narratives
- 1:29:12 – 1:53:20
Good Friday Experiment: mystical experience research and long-term ‘fruits’ of psychedelics
Rick revisits the 1962 Good Friday Experiment—psilocybin vs. active placebo in divinity students—to examine whether psychedelics can catalyze genuine mystical experience. He explains his own long-term follow-up work, emphasizing the “fruits test” (life outcomes) and the importance of honestly reporting both benefits and difficult events.
- •Experiment design and why it became a landmark study
- •Howard Thurman’s influence: mysticism linked to social/political action
- •Rick’s follow-up: reduced fear of death, increased ecumenism, deepened (symbolic) faith
- •Unreported adverse event (Thorazine tranquilization) and why transparency matters
- •Avoiding the twin traps: exaggerating benefits or hiding risks
- 1:53:20 – 2:01:32
Concord Prison Experiment: debunking recidivism claims and the necessity of aftercare
Rick describes tracking down records for Leary’s Concord Prison Experiment and discovering the recidivism ‘success’ was inflated via mismatched time windows—scientific fraud. Joe argues even real psychedelic benefit can’t overcome entrenched social conditions without sustained support; both emphasize integration, structure, and post-release resources.
- •Researchers dosing prisoners (and some researchers dosing too) to reduce power gaps
- •Lost records recovered; follow-up reveals manipulated comparisons (30 vs 10 months)
- •Why recidivism is a hard outcome without housing/support/community reintegration
- •Modern lesson: psychedelic sessions must be paired with aftercare systems
- •Parallel to veterans: structured transition out of military vs ‘you’re done’
- 2:01:32 – 2:09:43
Psychedelic Science conference, ‘net zero trauma by 2070,’ and scaling via institutions
Rick promotes MAPS’ large Denver conference while outlining a sweeping vision: reducing humanity’s trauma burden over generations. He cites Iceland policy interest (prisoners, victims, guards, police), Texas VA funding initiatives, and police training for de-escalating difficult trips—showing how institutional adoption is expanding.
- •Psychedelic Science (Denver) scale-up: thousands attending, major speakers, exhibits
- •Goal: net zero trauma by 2070; trauma as cumulative and multi-generational (epigenetics)
- •Iceland as potential national model (justice system + victims + law enforcement)
- •Texas legislature and VA studies: psilocybin and MDMA research funding
- •Police education for safe responses to psychedelic crises
- 2:09:43 – 2:17:55
MAPS at the crossroads: FDA timeline, public benefit corporation model, and ‘going public’ dilemma
Rick explains MAPS’ structure (nonprofit owning a public benefit pharmaceutical company), the strong Phase 3 PTSD results, and the near-term funding gap to FDA approval and sustainability. Joe challenges the ethics of mixing sacred substances with profit motives; Rick weighs philanthropy vs. investors and argues governance must protect public benefit.
- •Phase 3 outcomes: high responder rates and strong statistical significance
- •Funding needs: runway to FDA approval and then to operational sustainability
- •Public Benefit Corporation as a legal shield to prioritize public benefit over profit
- •Risks of patents/new molecules and pharma incentives vs. open access
- •Debate: if forced to raise investor capital, how to preserve mission control
- 2:17:55
Data exclusivity, FDA process realities, and how MAPS expects approval to work
Rick clarifies how off-patent drugs can still gain market protection via data exclusivity, reshaping the business case for funding MDMA therapy. He also lays out why he believes approval is likely: special protocol assessment agreement, inspection outcomes, bipartisan support, and clear efficacy/safety thresholds—while noting regulation and rollout may be the bigger challenge.
- •Reagan-era data exclusivity: 5 years (plus pediatric extension) US; 10 years EU
- •Why pharma often ignores this pathway despite its importance for MDMA
- •Special Protocol Assessment: negotiated Phase 3 design despite imperfect blinding
- •FDA approval hinges on statistical significance + safety + valid data collection
- •Post-FDA rescheduling timeline: DEA must act within 90 days
Parenting and drug education: honesty, rites of passage, and ‘do it with your parents’ strategy
As the episode winds down, Rick asks how Joe plans to talk to his kids about drugs, and Joe describes candid conversations about danger, illegality, and fentanyl contamination. Rick shares his own parenting experiment: offering supervised marijuana/MDMA at age 13 as a bar-mitzvah-age rite-of-passage option—only for his kids to refuse, making it an unexpectedly effective deterrent.
- •Joe’s approach: explain legality, dose certainty, and fentanyl contamination risks
- •Drug policy as a driver of harm via black-market adulteration
- •Rick’s bar mitzvah disappointment and the role of rites-of-passage expectations
- •Rick’s family approach: offer supervised experiences; kids initially reject it
- •The broader theme: education, context, and relationship matter more than fear messaging
